Related Experiment Videos
Nonfunctioning islet cell pancreatic cancer.
The Journal of the American Osteopathic Association
|June 1, 1989
Summary
Nonfunctioning islet cell tumors are rare pancreatic neuroendocrine tumors. Despite potential malignancy, their slow growth allows for long survival with aggressive surgical treatment.
Area of Science:
- Oncology
- Endocrinology
- Gastroenterology
Background:
- Neuroendocrine tumors (NETs) of the pancreas are categorized as functioning or nonfunctioning.
- Nonfunctioning islet cell tumors lack clinical evidence of hormonal hypersecretion.
Observation:
- Symptoms in nonfunctioning tumors typically result from mass effect, including jaundice, weight loss, and malaise.
- These tumors are more frequently malignant compared to their functioning counterparts.
Findings:
- Despite a higher likelihood of malignancy, nonfunctioning islet cell tumors exhibit slow growth patterns.
- Tumor size and malignant potential do not necessarily limit long-term patient survival.
Implications:
- Aggressive surgical intervention is recommended for nonfunctioning islet cell tumors.
- Early and decisive surgical management can lead to favorable long-term outcomes even in malignant cases.